v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income/(Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   33,893,409      
Beginning balance at Dec. 31, 2024 $ 2,503,405 $ 34 $ 12,305,250 $ 1,451 $ (9,803,330)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (106,213)       (106,213)
Stock-based compensation expense 16,261   16,261    
Other comprehensive (loss) income 215     215  
Release of restricted stock units (in shares)   1,403,449      
Release of restricted stock units 0 $ 1 (1)    
Ending balance (in shares) at Mar. 31, 2025   35,296,858      
Ending balance at Mar. 31, 2025 2,413,668 $ 35 12,321,510 1,666 (9,909,543)
Beginning balance (in shares) at Dec. 31, 2024   33,893,409      
Beginning balance at Dec. 31, 2024 2,503,405 $ 34 12,305,250 1,451 (9,803,330)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (309,175)        
Ending balance (in shares) at Sep. 30, 2025   36,160,998      
Ending balance at Sep. 30, 2025 2,239,963 $ 36 12,349,976 2,456 (10,112,505)
Beginning balance (in shares) at Mar. 31, 2025   35,296,858      
Beginning balance at Mar. 31, 2025 2,413,668 $ 35 12,321,510 1,666 (9,909,543)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (113,985)       (113,985)
Stock-based compensation expense 14,323   14,323    
Other comprehensive (loss) income 637     637  
Release of restricted stock units (in shares)   750,941      
Release of restricted stock units 0 $ 1 (1)    
Ending balance (in shares) at Jun. 30, 2025   36,047,799      
Ending balance at Jun. 30, 2025 2,314,643 $ 36 12,335,832 2,303 (10,023,528)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (88,977)       (88,977)
Stock-based compensation expense 14,144   14,144    
Other comprehensive (loss) income 153     153  
Release of restricted stock units (in shares)   113,199      
Ending balance (in shares) at Sep. 30, 2025   36,160,998      
Ending balance at Sep. 30, 2025 $ 2,239,963 $ 36 12,349,976 2,456 (10,112,505)
Beginning balance (in shares) at Dec. 31, 2025 40,331,360 40,331,360      
Beginning balance at Dec. 31, 2025 $ 2,577,862 $ 40 12,786,848 2,655 (10,211,681)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (93,187)       (93,187)
Stock-based compensation expense 16,793   16,793    
Other comprehensive (loss) income (782)     (782)  
Release of restricted stock units (in shares)   802,859      
Release of restricted stock units 0 $ 1 (1)    
Ending balance (in shares) at Mar. 31, 2026   41,134,219      
Ending balance at Mar. 31, 2026 $ 2,500,686 $ 41 12,803,640 1,873 (10,304,868)
Beginning balance (in shares) at Dec. 31, 2025 40,331,360 40,331,360      
Beginning balance at Dec. 31, 2025 $ 2,577,862 $ 40 12,786,848 2,655 (10,211,681)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (307,002)        
Ending balance (in shares) at Sep. 30, 2026 44,753,179 44,753,179      
Ending balance at Sep. 30, 2026 $ 2,453,519 $ 45 12,970,363 1,794 (10,518,683)
Beginning balance (in shares) at Mar. 31, 2026   41,134,219      
Beginning balance at Mar. 31, 2026 2,500,686 $ 41 12,803,640 1,873 (10,304,868)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (110,247)       (110,247)
Stock-based compensation expense 19,557   19,557    
Issuance of common stock under ESPP (in shares)   87,446      
Issuance of common stock under ESPP 4,593   4,593    
Other comprehensive (loss) income (33)     (33)  
Release of restricted stock units (in shares)   1,874,261      
Release of restricted stock units 0 $ 2 (2)    
Issuance of common stock and recognition of the Samsung Stock Purchase Agreement, including the deferred asset, net of tax benefit and issuance costs (in shares)   1,570,308      
Issuance of common stock and recognition of the Samsung Stock Purchase Agreement, including the deferred asset, net of tax benefit and issuance costs 128,098 $ 2 128,096    
Ending balance (in shares) at Jun. 30, 2026   44,666,234      
Ending balance at Jun. 30, 2026 2,542,654 $ 45 12,955,884 1,840 (10,415,115)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (103,568)       (103,568)
Stock-based compensation expense 14,109   14,109    
Other comprehensive (loss) income (46)     (46)  
Issuance of common stock pursuant to exercise of performance stock options (in shares)   26,452      
Issuance of common stock pursuant to exercise of performance stock options $ 370   370    
Release of restricted stock units (in shares)   60,493      
Ending balance (in shares) at Sep. 30, 2026 44,753,179 44,753,179      
Ending balance at Sep. 30, 2026 $ 2,453,519 $ 45 $ 12,970,363 $ 1,794 $ (10,518,683)